Photoswitchable Carbamazepine Analogs for Non-Invasive Neuroinhibition In Vivo

Area of Science:

• Medicinal Chemistry
• Pharmacology
• Photopharmacology

Background:

• Systemic drug administration often causes off-target adverse effects.
• Current antiseizure drugs, like carbamazepine, treat epilepsy and neuropathic pain but have unwanted systemic side effects.
• Photopharmacology offers a solution by using light-activated drugs for localized, on-demand therapeutic effects.

Purpose of the Study:

• To develop photoswitchable derivatives of carbamazepine for localized nerve signal inhibition.
• To explore novel azologization methods for tricyclic drug modification.
• To evaluate the efficacy and safety of these novel compounds.

Main Methods:

• Expanded ortho azologization to meta/para and N-bridged diazocine structures.
• Synthesized and characterized photoswitchable carbamazepine derivatives (Carbazopine-1 and Carbadiazocine).
• Tested in vitro and in vivo using zebrafish larvae and a rat model of neuropathic pain.

Main Results:

• Developed Carbazopine-1 and Carbadiazocine, which are photoswitchable using visible light (400-590 nm).
• Both compounds demonstrated photoswitchable activity in vitro and in vivo models.
• Carbadiazocine showed significant analgesic efficacy in a rat model of neuropathic pain with non-invasive illumination.

Conclusions:

• Validated the concept of ortho cryptoazologs and introduced Carbadiazocine as a promising photoswitchable drug candidate.
• Demonstrated the potential of photopharmacology to achieve localized, on-demand nerve signal modulation.
• These findings pave the way for safer and more targeted treatments for neuropathic pain and epilepsy.